Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 70, Issue 5, 2004, Pages 475-478

  Kim, Kyung Mee ^a,b   Jung, Byung Hwa ^a   Paeng, Ki Jung ^b   Kim, Sang Wook ^c   Chung, Bong Chul ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c College of Medicine   (South Korea)

Author keywords

F2 isoprostanes; Hemodialysis; Oxidative stress

Indexed keywords

ISOPROSTANE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GAS CHROMATOGRAPHY; HEMODIALYSIS; HUMAN; ION TRAP MASS SPECTROMETRY; KIDNEY FAILURE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 1842684040     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.10.001     Document Type: Article

References (21)

1. 2-isoprostanes during oxidative modification of low-density lipoprotein, Biochem. Biophys. Res. Commun. 200 (1994) 338-343.
2. B. Halliwell, J.M. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview, Methods Enzymol. 186 (1990) 1-85.
3. P.A. Southorn, G. Powis, Free radicals in medicine. II. Involvement in human disease, Mayo Clin. Proc. 63 (1988) 390-408.
4. D. Harman, The aging process, Proc. Natl. Acad. Sci. USA 78 (1981) 7124-7128.
5. J.D. Morrow, L.J. Roberts, The isoprostanes: unique bioactive products of lipid peroxidation, Prog. Lipid Res. 36 (1997) 1-21.
6. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism, Proc. Natl. Acad. Sci. USA 87 (1990) 9383-9387.
7. E. Dursun, T. Ozben, G. Suleymanlar, B. Dursun, G. Yakupoglu, Effect of hemodialysis on the oxidative stress and antioxidants, Clin. Chem. Lab. Med. 40 (2002) 1009-1013.
8. M. Morena, M. Martin-Mateo, J.P. Cristol, B. Canaud, Oxidative stress, hemo-incompatibility and complications of long-term dialysis, Nephrologie 23 (2002) 201-208.
9. 2-isoprostanes in patients on long-term hemodialysis, Kidney Int. 59 (2001) 1960-1966.
10. 2-isoprostane levels are elevated in chronic hemodialysis patients, Clin. Nephrol. 58 (2002) 190-197.
11. P.S. Lim, Y.M. Chang, L.M. Thien, N.P. Wang, C.C. Yang, T.T. Chen, W.M. Hsu, 8 iso-prostaglandin F(2alpha) as a useful clinical biomarker of oxidative stress in ESRD patients, Blood Purif. 20 (2002) 537-542.
12. 2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure, J. Chromatogr. B 667 (1995) 199-208.
13. C. Feillet-Coudray, E. Rock, C. Coudray, K. Grzelkowska, V. Azais-Braesco, D. Dardevet, A. Mazur, Lipid peroxidation and antioxidant status in experimental diabetes, Clin. Chim. Acta 284 (1999) 31-43.
14. R.A. Kloner, Does reperfusion injury exist in humans? J. Am. Coll. Cardiol. 21 (1993) 537-545.
15. C.R. Diaz-Velez, S. Garcia-Castineiras, E. Mendoza-Ramos, E. Hernandez-Lopez, Increased malondialdehyde in peripheral blood of patients with congestive heart failure, Am. Heart J. 131 (1996) 146-152.
16. C. Tetta, S. Biasioli, R. Schiavon, P. Inguaggiato, S. David, V. Panichi, M.L. Wratten, An overview of haemodialysis and oxidant stress, Blood Purif. 17 (1999) 118-126.
17. B.N. Becker, B.N. Himmelfarb, W.L. Henrich, R.M. Hakim, Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors, J. Am. Soc. Nephrol. 8 (1997) 475-486.
18. R.M. Hakim, P.J. Held, D.C. Stannard, R.A. Wolfe, F.K. Port, J.T. Daugirdas, L. Agodoa, Effect of the dialysis membrane on mortality of chronic hemodialysis patients, Kidney Int. 50 (1996) 566-570.
19. J.D. Morrow, L.J. Roberts 2nd, The isoprostanes. Current knowledge and directions for future research, Biochem. Pharmacol. 51 (1996) 1-9.
20. K. Moore, L.J. Roberts 2nd, Measurement of lipid peroxidation, Free Radic. Res. 28 (1998) 659-671.
21. J. Himmelfarb, E. McMonagle, E. McMenamin, Plasma protein thiol oxidation and carbonyl formation in chronic renal failure, Kidney Int. 58 (2000) 2571-2578.